References
Széplaki G, Boros AM, Szilágyi S, Osztheimer I, Jenei Z, Kosztin A, et al. Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure. Inflamm Res. 2016;65(12):933–40. doi:10.1007/s00011-016-0976-4.
Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology (Cambridge, Mass). 2010;21(1):128–38. doi:10.1097/EDE.0b013e3181c30fb2.
Leening MJ, Vedder MM, Witteman JC, Pencina MJ, Steyerberg EW. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician’s guide. Ann Intern Med. 2014;160(2):122–31. doi:10.7326/M13-1522.
Petretta M, Cuocolo A. Prediction models for risk classification in cardiovascular disease. Eur J Nucl Med Mol Imaging. 2012;39(12):1959–69. doi:10.1007/s00259-012-2254-1.
Hilden J, Gerds TA. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index. Stat Med. 2014;33(19):3405–14. doi:10.1002/sim.5804.
Leening MJ, Steyerberg EW, Van Calster B, D’Agostino RB Sr, Pencina MJ. Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective. Stat Med. 2014;33(19):3415–8. doi:10.1002/sim.6133.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: Andrew Roberts.
Rights and permissions
About this article
Cite this article
Petretta, M. Complement C3a levels and misinterpretation of classifier technology. Inflamm. Res. 66, 281–282 (2017). https://doi.org/10.1007/s00011-016-1016-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-016-1016-0